| Literature DB >> 27442020 |
E Riewe1, E Neubauer2, A C Pfeifer2, M Schiltenwolf2.
Abstract
OBJECTIVE: 10% of all individuals in Germany develop persistent symptoms due to nonspecific back pain (NSBP) causing up to 90% of direct and indirect expenses for health care systems. Evidence indicates a strong relationship between chronic nonspecific back pain and psychosocial risk factors. The Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) and the German Heidelberger Kurzfragebogen Rückenschmerz (HKF-R 10) are deemed valid in prediction of persistent pain, functional loss or amount of sick leave. This study provides and discusses validity criteria for these questionnaires using ROC-curve analyses. Quality measurements included sensitivity and specificity, likelihood-ratio related test-efficiencies and clinical utility in regard to predictive values.Entities:
Mesh:
Year: 2016 PMID: 27442020 PMCID: PMC4956238 DOI: 10.1371/journal.pone.0158850
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Test efficiencies in regard to likelihood-ratios.
| Positive Likelihood-Ratio | Negative Likelihood-Ratio | Test Efficiency |
|---|---|---|
| > 10 | < 0,10 | very high / very good |
| 5–10 | 0.1–0.2 | high /good |
| 2–5 | 0.2–0.5 | Moderate |
| 1–2 | 0.5–1.0 | Low |
based on Mühlhauser and Höldke, 1999; Bender, 2001
Dependencies between predictive values and prevalence.
| Prevalence | Very high Test Efficiency | Moderate Test Efficiency | ||
|---|---|---|---|---|
| Sensitivity and Specificity = 0.95, PLR = 19 | Sensitivity and Specificity = 0.7, PLR = 2.3 | |||
| PPV | NPV | PPV | NPV | |
| 90% | 99.4% | 67.9% | 95.5% | 21% |
| 50% | 95.0% | 95.0% | 70% | 70% |
| 10% | 67.9% | 99.4% | 21% | 95% |
| 1% | 16.1% | > 99.9% | 2.3% | 99.6% |
| 0.1% | 1.9% | 100% | 0.2% | > 99.9% |
| 0.01% | < 0.2% | 100% | < 0.1% | 100% |
based on Mühlhauser and Höldke 1999; Bender, 2001; Grimes and Schulz, 2005
Sum distributions of data sets in regard to outcome variables at baseline.
| First data collection | ÖMPSQ | HKF-R 10 |
|---|---|---|
| 4 unsigned declarations of consent | ||
| 1 written withdrawal from study | ||
| Raw data validation negative | 24 | 23 |
Sum distributions of data sets in regard to outcome variables at follow-up.
| Follow-Up | ÖMPSQ | HKF-R 10 | ||
|---|---|---|---|---|
| N = 133 of 265 | Pain | Sick Leave | Fkt | Pain |
| Missing outcome variables (by list) | 0 | 17 | 0 | 0 |
| Valid data sets at baseline without bonds to outcome variables (by cases) | 11 | 8 | 11 | 5 |
ROC-Analyses—Areas Under the Curve.
| Test result Variables: Total Scores | TN | FP | TP | FN | Prevalence | Area | Std. Error | Asymptotic Sig. | Asymptotic 95% Confidence Interval | |
|---|---|---|---|---|---|---|---|---|---|---|
| Lower Bound | Upper Bound | |||||||||
| ÖMPSQ Pain | 46 | 15 | 44 | 17 | 50% | 0.785 | 0.041 | 0.000 | 0.706 | 0.865 |
| ÖMPSQ Sick leave | 58 | 10 | 25 | 15 | 37% | 0.738 | 0.054 | 0.000 | 0.632 | 0.843 |
| ÖMPSQ Functional Ability | 33 | 25 | 62 | 2 | 52% | 0.818 | 0.038 | 0.000 | 0.742 | 0.893 |
| HKF-R10 Pain | 32 | 6 | 45 | 45 | 70% | 0.678 | 0.050 | 0.001 | 0.581 | 0.775 |
Each test result variable has at least one tie between the positive actual state group and the negative actual state group. Statistics may be biased.
Abbreviations: TN = True Negative; FP = False Positive; TP = True Positive; FN = False Negative
a. Under the nonparametric assumption
b. Null hypothesis: true area = 0.5
ROC-Analyses—Cut-off associated parameters of validity for each screening-tool taken from the ROC-curve coordinate point.
| Instrument by Outcome | Cut-Off | Prevalence | Sensitivity | Specificity | PLR | NLR | PPV | NPV | ACC |
|---|---|---|---|---|---|---|---|---|---|
| ÖMPSQ | 10% | 0.25 | 0.96 | ||||||
| Pain | 76 | 50% | 0.87 | 0.53 | 1.83 | 0.25 | 0.65 | 0.80 | 0.70 |
| 10% | 0.17 | 0.97 | |||||||
| 10% | 0.32 | 0.95 | |||||||
| ÖMPSQ | 84 | 37% | 0.70 | 0.71 | 2.38 | 0.43 | 0.58 | 0.80 | 0.70 |
| Sick Leave | 10% | 0.21 | 0.96 | ||||||
| 76 | 37% | 0.80 | 0.44 | 1.43 | 0.45 | 0.46 | 0.79 | 0.57 | |
| 10% | 0.14 | 0.95 | |||||||
| ÖMPSQ | 10% | 0.20 | 0.99 | ||||||
| Functional | 84 | 52% | 0.70 | 0.76 | 2.91 | 0.39 | 0.76 | 0.70 | 0.73 |
| Ability | 10% | 0.25 | 0.96 | ||||||
| 76 | 50% | 0.92 | 0.60 | 2.33 | 0.13 | 0.72 | 0.88 | 0.77 | |
| 10% | 0.21 | 0.99 | |||||||
| 10% | 0.26 | 0.94 | |||||||
| HKF-R 10 | 37 | 70% | 0.62 | 0.63 | 1.69 | 0.60 | 0.80 | 0.41 | 0.63 |
| Pain | 10% | 0.16 | 0.94 | ||||||
| 20 | 70% | 0.86 | 0.29 | 1.20 | 0.50 | 0.74 | 0.46 | 0.69 | |
| 10% | 0.12 | 0.95 |
Values rounded; rows with optimal cut-offs in regard to sensitivity and specificity (calculated by the Youden-Index) are outlined bold
Abbreviations: PPV/NPV = positive/negative predictive value; PLR/NLR = positive/negative likelihoodratio; ACC = Accuracy
a. Cut-Off example with a balanced proportion between sensitivity and specificity
b. Cut-Off example with a sensitivity of 80% at minimum
c. prevalence within the sample
d. estimated prevalence in the German population